Role of Birds in Transmitting Zoonotic Pathogens (Paperback, 2021)

Chapter 1_Introduction and Objectives.- Chapter 2. Presentation of bird migration.- Chapter 2.1.Taxonomic groups involved with migration.- Chapter 2.2. Evolution.- Chapter 2.3. Route of bird migration.- Chapter 2.4. Adaptations and population-level scale.- Chapter 2.5. Flyways and stop-overs.- Chapter 2.6. Significance in disease transmission.- Chapter 3. Bacterial Diseases.- Chapter 3.1. Campylobacter.- Chapter 3.1.1. Introduction.- Chapter 3.1.2. Etiology and classification.- Chapter 3.1.3. Epizootiology.- Chapter 3.1.4. Pathogenesis and mode of transmission.- Chapter 3.1.5. Campylobacteriosis in birds.- Chapter 3.1.6. Public health concerns.- Chapter 3.1.7. Clinical signs and pathological changes.- Chapter 3.1.8. Treatment and control.- Chapter 3.2. Chlamydiosis (Psittacosis, Ornithosis) .- Chapter 3.2.1. Historical background.- Chapter 3.2.2. Etiology and Classification.- Chapter 3.2.3. Epizootiology.- Chapter 3.2.4. Transmission between different birds.- Chapter 3.2.5. Chlamydiosis in Ducks and Geese.- Chapter 3.2.6. Chlamydiosis in human beings.- Chapter 3.2.7. Clinical signs and pathological changes.- Chapter 3.2.8. Treatment and control.- Chapter 3.3. Collibacillosis (E. coli) .- Chapter 3.3.1. Introduction and Historical background.- Chapter 3.3.2. Etiology and classification.- Chapter 3.3.3. Antigenic structure of E. coli.- Chapter 3.3.4. Virulence associated factors.- Chapter 3.3.5. Epizootiology.- Chapter 3.3.6. Escherichia coli ,Wild Birds and the public health concerns.- Chapter 3.3.7. Clinical signs and pathological changes.- Chapter 3.3.8. Treatment and control.- Chapter 3.4.  Salmonellosis.- Chapter 3.4.1. Introduction.- Chapter 3.4.2. Etiology.- Chapter 3.4.3. Epizootiology.- Chapter 3.4.4. Wild birds as a carrier for Salmonellosis.- Chapter 3.4.5. Modes of transmission and Pathogenesis.- Chapter 3.4.6. Salmonellosis and public health concerns.- Chapter 3.4.7. Clinical signs and pathological changes.- Chapter 3.4.8. Treatment and control.- Chapter 3.5. Avian Tuberculosis.- Chapter 3.5.1. Introduction and Historical background.- Chapter 3.5.2. Etiology.- Chapter 3.5.2. Epizootiology.- Chapter 3.5.3. Pathogenesis.- Chapter 3.5.4. Mycobacterium in wild birds.- Chapter 3.5.5. Public health concerns to Mycobacteriosis.- Chapter 3.5.6. Clinical signs and pathological changes.- Chapter 3.5.7. Treatment and control. .- Chapter 3.6. Lyme Disease (Borrelia spp) .- Chapter 3.6.1. Introduction and Historical background.- Chapter 3.6.2. Etiology.- Chapter 3.6.3. Epizootiology.- Chapter 3.6.4. Avian Spirochetosis.- Chapter 3.6.5. Lyme Borreliosis in North America.- Chapter 3.6.6. Lyme Borreliosis in Europe.- Chapter 3.6.7. Pathogenesis.- Chapter 3.6.8. Clinical signs and pathological changes.- Chapter 3.6.9. Treatment and control.- Chapter 3.7. Avian Erysipeplas.- Chapter 3.7.1. Introduction and Historical background.- Chapter 3.7.2. Etiology.- Chapter 3.7.3. Epizootiology.- Chapter 3.7.4. Public health and animal health concerns.- Chapter 3.7.5. Erysiplothrix impact on the wild birds.- Chapter 3.7.6. Pathogenesis.- Chapter 3.7.7. Clinical signs and pathological changes.- Chapter 3.7.8. Treatment and control.- Chapter 3.8. Clostridia disease (Avian Botulism) .- Chapter 3.8.1. Introduction and Historical background.- Chapter 3.8.2. Etiology.- Chapter 3.8.3. Epizootiology.- Chapter 3.8.4. Public health concerns.- Chapter 3.8.5. Pathogenesis.- Chapter 3.8.6. Clinical signs and pathology.- Chapter 3.8.7. Treatment and control.- Chapter 3.9. Avian Cholera.- Chapter 3.9.1. Introduction and Historical background.- Chapter 3.9.2. Epizootiology.- Chapter 3.9.3. Pathogenesis.- Chapter 3.9.4. Public health and animal health concerns.- Chapter 3.9.5. Clinical signs and pathological changes.- Chapter 3.9.6. Impact of P. multocida on the wildlife populations.- Chapter 3.9.7. Treatment and control.- Chapter 3.10.  Spotted Fever Group of Rickettsiales.- Chapter 3.10.1. Introduction and Historical background.- Chapter 3.10.2. Epizootiology and Pathogenesis.- Chapter 3.10.3. Clinical signs and pathology.- Chapter 3.10.4. Public health and animal health concerns.- Chapter 3.10.5. Treatment and control.- Chapter 4. Viral Diseases.- Chapter 4.1.  Flaviviruses (West Nile Virus and Japanese encephalitis virus).- Chapter 4.1.1. Introduction and Historical background.- Chapter 4.1.2. Etiology.- Chapter 4.1.3. Epizootiology and pathogenesis.- Chapter 4.1.4. Natural Host and Age susceptibility.- Chapter 4.1.5. Mode of transmission and Incubation period.- Chapter 4.1.6. Clinical signs, Necropsy finding and Pathological changes.- Chapter 4.1.7. Disease in human.- Chapter 4.1.8. Prevention and control measures and vaccination protocols.- Chapter 4.2. Togavirus (Western Equine encephalitis virus).- Chapter 4.2.1. Introduction and Historical background.- Chapter 4.2.2. Etiology.- Chapter 4.2.3. Epizootiology and pathogenesis.- Chapter 4.2.4. Natural Host and Age susceptibility.- Chapter 4.2.5. Mode of transmission and Incubation period.- Chapter 4.2.6. Clinical signs, Necropsy finding and Pathological changes.- Chapter 4.2.7. Immune response and Diagnosis.- Chapter 4.2.8. Control measures and vaccination protocols.- Chapter 4.3. Avian Influenza.- Chapter 4.3.1. Introduction.- Chapter 4.3.2. Etiology and classification.- Chapter 4.3.3. Epizootiology.- Chapter 4.3.4. Incidence and distribution of AI.- Chapter 4.3.5. Hosts and Host restrictions.- Chapter 4.3.6. Methods of transmission.- Chapter 4.3.7. Public Health Concerns.- Chapter 4.3.8. AI impact on the wild life population.- Chapter 4.3.9. Domestic animal concerns regarding AI.- Chapter 4.3.10. Clinical signs.- Chapter 4.3.11. Treatment and control.- Chapter 4.4. Newcastle disease virus (NDV) and other avian paramyxoviruses.- Chapter 4.4.1. Introduction, Synonyms, and Historical background.- Chapter 4.4.2. Etiology and strain classification.- Chapter 4.4.3. Epizootiology.- Chapter 4.4.4. Geographical distribution and incidence of the NDV.- Chapter 4.4.5. NDV modes of spread.- Chapter 4.4.6.NDV Public Health Concerns.- Chapter 4.4.7. Clinical signs.- Chapter 4.4.8. Necropsy findings.- Chapter 4.4.9. Pathogenesis.- Chapter 4.4.10. Diagnosis and Control measures.- Chapter 4.4.11. Treatment and control.- Chapter 4.5. Circovirus.- Chapter 4.5.1. Introduction.- Chapter 4.5.2. Etiology and classification.- Chapter 4.5.3. Psittacine Beak and Feather Disease.- Chapter 4.5.4. Historical background and introduction.- Chapter 4.5.5. Epizootiology and modes of transmission.- Chapter 4.5.6. Pathogenesis.- Chapter 4.5.7. Public health and animal health concerns.- Chapter 4.5.8. Goose and Duck Circoviruses.- Chapter 4.5.9. Diagnosis and Control measures.- Chapter 4.6. Rotavirus.- Chapter 4.6.1. Introduction and Historical background.- Chapter 4.6.2. Etiology and classification.- Chapter 4.6.3. Epizootiology.- Chapter 4.6.4. Pathogenesis.- Chapter 4.6.5. Clinical signs and pathology.- Chapter 4.6.6. Control measures.- Chapter 4.7. Usutu virus.- Chapter 4.7.1 Introduction and Historical background.- Chapter 4.7.2. Etiology and classification.- Chapter 4.7.3. Epizootiology.- Chapter 4.7.4. Pathogenesis.- Chapter 4.7.5. Clinical signs and pathology.- Chapter 4.7.6.  Diagnosis.- Chapter 4.7.7.  Control measures.- Chapter 5. Parasitic diseases.- Chapter 5. Cryptosporidiosis.- Chapter 5.1. Introduction.- Chapter 5.1.1. Epizootiology.- Chapter 5.1.2. Modes of transmission.- Chapter 5.1.3. Prevalence of the cryptosporidiosis.- Chapter 5.1.4. Cryptosporidiosis in Canada Geese.- Chapter 5.1.5. Pathogenesis and Cryptosporidiosis in human beings.- Chapter 5.1.6. Diagnosis and Control measures.- Chapter 5.1.7. Treatment and control.- Chapter 5.2. Giardiasis.- Chapter 5.2.1. Introduction.- Chapter 5.2.2. Epizootiology.- Chapter 5.2.3. Mode of transmission.- Chapter 5.2.4. Pathogenesis.- Chapter 5.2.5. Giardiasis and Canada Goose.- Chapter 5.2.6 Giardiasis in human beings.- Chapter 5.2.7. Diagnosis and Control measures.- Chapter 5.2.8. Treatment and control.- Chapter 5.3. Role of birds in tick-borne diseases .- Chapter 5.3.1. Introduction.- Chapter 5.3.2. Epizootiology and Mode of transmission.- Chapter 5.3.3. Tick-borne diseases.- Chapter 5.3.4. CCHF and Dermanyssus gallinae.- Chapter 5.3.5. Diagnosis and Control measures.- Chapter 5.3.6. Treatment and control.- Chapter 6. Mycotic Diseases.- Chapter 6.1. Aspergillosis- Chapter 6.1.1. Introduction and Historical background- Chapter 6.1.2. Epizootiology- Chapter 6.1.3. Mode of transmission- Chapter 6.1.4. Pathogenesis- Chapter 6.1.5. Public health and animal health concerns- Chapter 6.1.6. Clinical signs and necropsy findings- Chapter 6.1.7. Diagnosis and Control measures- Chapter 6.1.8. Treatment and control- Chapter 6.2. Dermatophytosis (Favus) - Chapter 6.3. Dactylariosis- Chapter 6.4. Histoplasmosis- Chapter 6.5. Cryptococcosis. - Chapter 6.6. Role of birds as vectors of fluke worms (Trichobilharzia szidati) - Chapter 7. Sporadic diseases affecting wild birds and of non-zoonotic importance- Chapter 7.1. Mycoplsmosis- Chapter 7.2. Ornithobacterium rhinotraheale- Chapter 7.3. Avian Herpesvirus- Chapter 7.4.  Avian Pox- Chapter 7.5 Avian adenoviruses- Chapter 7.6. Retrovirus infections- Chapter 7.7. Paplomaviruses and Polyomaviruses.- Chapter 8. Conclusions.- Chapter 9. Glossary- Chapter 10. List of abbreviations- Chapter 11. References.